From: The association between oxidized low-density lipoprotein antibodies and hematological diseases
Group | Gender (M/F) | Age | BMI | SBP* | DBP+ |
---|---|---|---|---|---|
cases with non lymphatic leukemia | 49/49 | 43.2 ± 18.18 | 23.2 ± 3.36 | 126.0 ± 16.33 | 68.9 ± 12.05 |
cases with lymphatic leukemia | 25/35 | 31.1 ± 15.40 | 23.0 ± 3.60 | 123.1 ± 9.30 | 79.3 ± 6.2 |
cases with Hemolytic anemia | 30/22 | 50.5 ± 20.40 | 23.7 ± 3.99 | 133.8 ± 19.62 | 66.1 ± 10.04 |
cases with immunothrombocytopenia | 25/41 | 43.7 ± 17.37 | 22.5 ± 3.11 | 123.7 ± 13.54 | 76.9 ± 9.99 |
cases with multiple myeloma | 32/25 | 57.3 ± 8.49 | 24.9 ± 2.73 | 135.0 ± 13.28 | 81.3 ± 12.24 |
cases with non Kochkin’s | 22/36 | 48.4 ± 12.45 | 26.6 ± 4.36 | 109.7 ± 11.49 | 73.6 ± 8.97 |
cases with myelodysplastic syndrome | 25/30 | 61.9 ± 13.57 | 25.1 ± 3.67 | 122.2 ± 13.10 | 67.7 ± 10.15 |
patients with primary hypertension | 47/43 | 56.5 ± 10.87 | 25.8 ± 3.49 | 159.2 ± 17.15 | 94.2 ± 11.03 |
healthy normal persons+ | 40/50 | 45.4 ± 11.67 | 24.5 ± 3.35 | 115.3 ± 16.31 | 78.2 ± 10.03 |
F/x 2 | 10.724 | 16.662 | 4.766 | 40.045 | 30.959 |
P | 0.218 | <0.001 | 0.02 | <0.001 | <0.001 |